GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,365,000 | +20.7% | 77,251 | +22.2% | 0.10% | +23.8% |
| Q4 2021 | $2,788,000 | +71.3% | 63,217 | +48.4% | 0.08% | +53.8% |
| Q3 2021 | $1,628,000 | +64.4% | 42,594 | +71.3% | 0.05% | +67.7% |
| Q2 2021 | $990,000 | +26.8% | 24,867 | +13.6% | 0.03% | +6.9% |
| Q1 2021 | $781,000 | +127.0% | 21,887 | +134.1% | 0.03% | +107.1% |
| Q4 2020 | $344,000 | +0.9% | 9,351 | +3.0% | 0.01% | -12.5% |
| Q3 2020 | $341,000 | +8.3% | 9,078 | +17.7% | 0.02% | -5.9% |
| Q2 2020 | $315,000 | +7.9% | 7,713 | +0.4% | 0.02% | -10.5% |
| Q1 2020 | $292,000 | -14.6% | 7,684 | +5.5% | 0.02% | +5.6% |
| Q4 2019 | $342,000 | +37.3% | 7,285 | +17.0% | 0.02% | +20.0% |
| Q3 2019 | $249,000 | 0.0% | 6,225 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $249,000 | -27.4% | 6,225 | -24.3% | 0.02% | -37.5% |
| Q1 2019 | $343,000 | -2.8% | 8,219 | -11.3% | 0.02% | -22.6% |
| Q4 2018 | $353,000 | -6.1% | 9,261 | -1.2% | 0.03% | +14.8% |
| Q3 2018 | $376,000 | -34.0% | 9,370 | -33.6% | 0.03% | -37.2% |
| Q2 2018 | $570,000 | -3.7% | 14,113 | -6.9% | 0.04% | -8.5% |
| Q1 2018 | $592,000 | +1.7% | 15,153 | -7.6% | 0.05% | -7.8% |
| Q4 2017 | $582,000 | +248.5% | 16,406 | +300.0% | 0.05% | +168.4% |
| Q3 2017 | $167,000 | -4.6% | 4,102 | +1.4% | 0.02% | -17.4% |
| Q2 2017 | $175,000 | +27.7% | 4,047 | +24.2% | 0.02% | +15.0% |
| Q1 2017 | $137,000 | -16.0% | 3,259 | -13.5% | 0.02% | -35.5% |
| Q3 2016 | $163,000 | +16.4% | 3,768 | +16.3% | 0.03% | -3.1% |
| Q2 2016 | $140,000 | -14.6% | 3,241 | -19.8% | 0.03% | -28.9% |
| Q1 2016 | $164,000 | -6.8% | 4,042 | -7.3% | 0.04% | -21.1% |
| Q4 2015 | $176,000 | -10.2% | 4,361 | -14.5% | 0.06% | -3.4% |
| Q3 2015 | $196,000 | +24.8% | 5,100 | +36.0% | 0.06% | +28.3% |
| Q2 2015 | $157,000 | +14.6% | 3,750 | +28.3% | 0.05% | +21.1% |
| Q1 2015 | $137,000 | +5.4% | 2,923 | -0.9% | 0.04% | -7.3% |
| Q4 2014 | $130,000 | -74.5% | 2,950 | -73.4% | 0.04% | -78.0% |
| Q3 2014 | $509,000 | -7.1% | 11,070 | +8.1% | 0.19% | -19.8% |
| Q2 2014 | $548,000 | +199.5% | 10,242 | +198.4% | 0.23% | +152.2% |
| Q4 2013 | $183,000 | – | 3,432 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |